...We Welcome You to the Zenith Epigenetics Hub On AGORACOM
Zenith's Lead BET Inhibitor ZEN-3694 is Currently Being Evaluated in a Phase 2 Prostate Cancer Clinical Trial
fast facts
- name Zenith Epigenetics
- symbol ZZXY
- exchange OTCBB
- financials View Filings
- shares outstanding 127,625,628
- industry Technology & Medical
- transfer agent Computershare Trust Company of Canada
- website http://www.zenithepigenet...
recent updates
-
WebLink -
Zenith_AGM_2018_09_12... (rough) -
-
WebLink -
AGM 9/12/18 Corporate Update Slide Deck -
-
WebLink -
Zenith News
most recent messages
